ORIC Pharmaceuticals (ORIC) Short Interest Ratio & Short Volume $5.57 -0.14 (-2.45%) Closing price 04:00 PM EasternExtended Trading$5.57 +0.00 (+0.02%) As of 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ORIC Pharmaceuticals Short Interest DataORIC Pharmaceuticals (ORIC) has a short interest of 13.26 million shares, representing 19.77% of the float (the number of shares available for trading by the public). This marks a -12.19% decrease in short interest from the previous month. The short interest ratio (days to cover) is 12.6, indicating that it would take 12.6 days of the average trading volume of 636,119 shares to cover all short positions.Current Short Interest13,260,000 sharesPrevious Short Interest15,100,000 sharesChange Vs. Previous Month-12.19%Dollar Volume Sold Short$66.83 millionShort Interest Ratio12.6 Days to CoverLast Record DateApril 15, 2025Outstanding Shares71,085,000 sharesShort Percent of Float19.77%Today's Trading Volume611,282 sharesAverage Trading Volume636,119 sharesToday's Volume Vs. Average96% Short Selling ORIC Pharmaceuticals? Sign up to receive the latest short interest report for ORIC Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartORIC Short Interest Over TimeORIC Days to Cover Over TimeORIC Percentage of Float Shorted Over Time ORIC Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202513,260,000 shares $66.83 million -12.2%19.8%12.6 $5.04 3/31/202515,100,000 shares $84.26 million +8.1%22.5%14.1 $5.58 3/15/202513,970,000 shares $108.83 million +3.2%20.8%14.7 $7.79 2/28/202513,540,000 shares $108.73 million +12.5%20.2%15.3 $8.03 2/15/202512,040,000 shares $100.65 million +15.2%17.9%14.2 $8.36 1/31/202510,450,000 shares $108.89 million -0.7%N/A15.1 $10.42 1/15/202510,520,000 shares $114.35 million -8.0%N/A22.2 $10.87 12/31/202411,440,000 shares $92.32 million +2.1%N/A26.8 $8.07 12/15/202411,210,000 shares $95.51 million -0.7%N/A28.7 $8.52 11/30/202411,290,000 shares $111.77 million -1.5%N/A25.8 $9.90 Get the Latest News and Ratings for ORIC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ORIC Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/15/202411,460,000 shares $97.41 million -1.6%N/A25.5 $8.50 10/31/202411,650,000 shares $109.28 million -2.9%N/A25.5 $9.38 10/15/202412,000,000 shares $114.24 million -2.1%N/A26.7 $9.52 9/30/202412,260,000 shares $125.67 million -1.0%N/A25 $10.25 9/15/202412,380,000 shares $122.44 million -2.3%N/A21 $9.89 8/31/202412,670,000 shares $131.39 million -1.5%N/A23.1 $10.37 8/15/202412,860,000 shares $139.27 million +7.9%N/A22.3 $10.83 7/31/202411,920,000 shares $133.50 million +4.8%N/A21.8 $11.20 7/15/202411,380,000 shares $122.34 million -2.7%N/A20.9 $10.75 6/30/202411,700,000 shares $82.72 million +4.4%N/A22.1 $7.07 6/15/202411,210,000 shares $83.96 million +3.3%N/A24.6 $7.49 5/31/202410,850,000 shares $97.54 million +2.2%N/A21.5 $8.99 5/15/202410,620,000 shares $98.87 million +3.7%N/A18.9 $9.31 4/30/202410,240,000 shares $90.42 million +8.7%N/A17.8 $8.83 4/15/20249,420,000 shares $89.87 million +15.7%N/A16.8 $9.54 3/31/20248,140,000 shares $111.93 million +17.5%N/A13.9 $13.75 3/15/20246,930,000 shares $104.64 million +6.8%N/A13 $15.10 2/29/20246,490,000 shares $82.68 million -0.8%N/A13.6 $12.74 2/15/20246,540,000 shares $73.58 million +0.9%N/A16.1 $11.25 1/31/20246,480,000 shares $71.22 million -25.6%N/A16.5 $10.99 1/15/20248,710,000 shares $74.91 million +0.1%28.0%19.8 $8.60 12/31/20238,700,000 shares $80.04 million +0.4%27.9%20.9 $9.20 12/15/20238,670,000 shares $80.72 million -2.8%27.8%18.7 $9.31 11/30/20238,920,000 shares $70.47 million +1.7%28.6%19 $7.90 11/15/20238,770,000 shares $57.27 million +14.9%28.1%20.3 $6.53 10/31/20237,630,000 shares $51.12 million +6.0%24.1%17.5 $6.70 10/15/20237,200,000 shares $40.07 million +4.8%22.7%18.9 $5.57 9/30/20236,870,000 shares $41.56 million +10.3%21.7%20 $6.05 9/15/20236,230,000 shares $51.71 million +2.1%19.7%18.1 $8.30 8/31/20236,100,000 shares $54.66 million +3.6%19.2%14.9 $8.96Musk's warning signal: Prepare before the cascade begins (Ad)When Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t. With 40+ years of market modeling, he says Musk’s move wasn’t about efficiency — it was a signal. And what’s coming next could divide the market into winners and losers faster than anyone expects. Watch this urgent video briefing now.Watch the Musk market warning before the dominoes fall 8/15/20235,890,000 shares $51.42 million +1.2%18.6%13.7 $8.73 7/31/20235,820,000 shares $48.66 million -2.0%21.5%15 $8.36 7/15/20235,940,000 shares $46.27 million No Change22.0%15.7 $7.79 6/30/20235,940,000 shares $46.09 million +19.5%19.0%17 $7.76 6/15/20234,970,000 shares $31.96 million +15.1%15.9%15.4 $6.43 5/31/20234,320,000 shares $21.77 million +0.9%13.8%23.1 $5.04 5/15/20234,280,000 shares $22.13 million +0.9%13.7%27.5 $5.17 4/30/20234,240,000 shares $21.92 million No Change13.6%24.4 $5.17 4/15/20234,240,000 shares $25.61 million +1.7%13.6%22.6 $6.04 3/31/20234,170,000 shares $23.77 million +2.0%14.3%18.4 $5.70 3/15/20234,090,000 shares $17.71 million -1.5%14.1%4.1 $4.33 2/28/20234,150,000 shares $18.38 million No Change16.3%4.2 $4.43 2/15/20234,150,000 shares $19.92 million -2.8%16.3%4.2 $4.80 1/31/20234,270,000 shares $24.17 million +11.2%16.8%4.4 $5.66 1/15/20233,840,000 shares $22.73 million +8.5%15.1%4.1 $5.92 12/30/20223,540,000 shares $20.85 million +45.1%14.0%3.9 $5.89 12/15/20222,440,000 shares $7.93 million -1.2%8.0%3.1 $3.25 11/30/20222,470,000 shares $8.87 million -6.4%8.1%25.6 $3.59 11/15/20222,640,000 shares $9.27 million -0.4%8.7%28.2 $3.51 10/31/20222,650,000 shares $7.08 million -0.8%8.7%31.7 $2.67 10/15/20222,670,000 shares $7.40 million -1.1%8.8%23.9 $2.77 9/30/20222,700,000 shares $8.64 million No Change8.9%22.2 $3.20 9/15/20222,700,000 shares $9.07 million +1.1%8.9%12.5 $3.36 8/31/20222,670,000 shares $9.24 million -3.3%8.8%11.3 $3.46 8/15/20222,760,000 shares $13.00 million -0.7%9.1%9.7 $4.71 7/31/20222,780,000 shares $10.17 million -2.1%9.2%7.7 $3.66 7/15/20222,840,000 shares $12.13 million -6.6%9.4%7.2 $4.27 6/30/20223,040,000 shares $13.62 million -30.3%10.0%6.6 $4.48 6/15/20224,360,000 shares $17.35 million -2.5%14.4%7.5 $3.98 5/31/20224,470,000 shares $14.93 million -8.4%15.3%6.4 $3.34 5/15/20224,880,000 shares $13.71 million +38.6%16.7%7.2 $2.81 4/30/20223,520,000 shares $11.69 million +32.3%11.6%5.6 $3.32 4/15/20222,660,000 shares $11.97 million +4.3%8.8%4.4 $4.50 3/31/20222,550,000 shares $13.62 million -23.9%8.4%4.7 $5.34 3/15/20223,350,000 shares $20.50 million -4.3%10.8%8.2 $6.12 2/28/20223,500,000 shares $27.16 million +10.4%11.3%16.6 $7.76 2/15/20223,170,000 shares $28.56 million +12.0%10.3%15.9 $9.01 1/31/20222,830,000 shares $27.99 million +14.1%9.2%15.2 $9.89 1/15/20222,480,000 shares $31.74 million -6.4%8.0%14.6 $12.80 12/31/20212,650,000 shares $38.96 million -7.3%8.6%15 $14.70 12/15/20212,860,000 shares $36.87 million +1.4%9.3%10.8 $12.89 11/30/20212,820,000 shares $39.03 million -3.4%9.1%10.3 $13.84 11/15/20212,920,000 shares $51.22 million +0.3%9.5%10.7 $17.54 10/29/20212,910,000 shares $42.60 million -1.4%9.8%10.3 $14.64 10/15/20212,950,000 shares $47.88 million -2.0%9.9%10.9 $16.23 9/30/20213,010,000 shares $62.94 million -2.0%10.1%10.8 $20.91 9/15/20213,070,000 shares $76.93 million -5.0%10.3%14 $25.06 8/31/20213,230,000 shares $71.35 million -3.6%10.8%15.5 $22.09 8/13/20213,350,000 shares $62.41 million -0.3%11.2%15.4 $18.63 7/30/20213,360,000 shares $55.94 million +6.7%11.5%15.8 $16.65Musk's warning signal: Prepare before the cascade begins (Ad)When Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t. With 40+ years of market modeling, he says Musk’s move wasn’t about efficiency — it was a signal. And what’s coming next could divide the market into winners and losers faster than anyone expects. Watch this urgent video briefing now.Watch the Musk market warning before the dominoes fall 7/15/20213,150,000 shares $60.95 million -42.8%10.8%14.1 $19.35 6/30/20215,510,000 shares $97.47 million -2.7%18.9%25.3 $17.69 6/15/20215,660,000 shares $106.41 million +3.1%19.4%27.4 $18.80 5/28/20215,490,000 shares $125.45 million -1.6%18.9%24.3 $22.85 5/14/20215,580,000 shares $135.26 million +1.6%19.2%25 $24.24 4/30/20215,490,000 shares $135.49 million +3.8%19.2%24 $24.68 4/15/20215,290,000 shares $112.62 million +11.4%18.5%22.1 $21.29 3/31/20214,750,000 shares $112.43 million +31.6%16.8%16.3 $23.67 3/15/20213,610,000 shares $110.36 million +4.3%12.8%11.2 $30.57 2/26/20213,460,000 shares $120.68 million +1.2%15.1%11.4 $34.88 2/12/20213,420,000 shares $112.93 million -1.2%15.0%10.9 $33.02 1/29/20213,460,000 shares $105.53 million +21.4%12.3%9.8 $30.50 1/15/20212,850,000 shares $95.48 million No Change10.2%8.3 $33.50 ORIC Short Interest - Frequently Asked Questions What is ORIC Pharmaceuticals' current short interest? Short interest is the volume of ORIC Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 13,260,000 shares of ORIC short. 19.77% of ORIC Pharmaceuticals' shares are currently sold short. Learn More on ORIC Pharmaceuticals' current short interest. What is a good short interest ratio for ORIC Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ORIC shares currently have a short interest ratio of 13.0. Learn More on ORIC Pharmaceuticals's short interest ratio. Which institutional investors are shorting ORIC Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of ORIC Pharmaceuticals: Group One Trading LLC, Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for ORIC Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 19.77% of ORIC Pharmaceuticals' floating shares are currently sold short. Is ORIC Pharmaceuticals' short interest increasing or decreasing? ORIC Pharmaceuticals saw a decline in short interest in the month of April. As of April 15th, there was short interest totaling 13,260,000 shares, a decline of 12.2% from the previous total of 15,100,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does ORIC Pharmaceuticals' short interest compare to its competitors? 19.77% of ORIC Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to ORIC Pharmaceuticals: Vera Therapeutics, Inc. (12.42%), Travere Therapeutics, Inc. (14.71%), Structure Therapeutics Inc. (12.89%), Mesoblast Limited (2.64%), Evotec SE (0.20%), Indivior PLC (2.18%), Ocular Therapeutix, Inc. (9.29%), Amphastar Pharmaceuticals, Inc. (8.47%), Ardelyx, Inc. (13.55%), Dyne Therapeutics, Inc. (18.94%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks. What does it mean to sell short ORIC Pharmaceuticals stock? Short selling ORIC is an investing strategy that aims to generate trading profit from ORIC Pharmaceuticals as its price is falling. ORIC shares are trading down $0.14 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ORIC Pharmaceuticals? A short squeeze for ORIC Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ORIC, which in turn drives the price of the stock up even further. How often is ORIC Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ORIC, twice per month. The most recent reporting period available is April, 15 2025. More Short Interest Resources from MarketBeat Related Companies VERA Short Interest TVTX Short Interest GPCR Short Interest MESO Short Interest EVO Short Interest INDV Short Interest OCUL Short Interest AMPH Short Interest ARDX Short Interest DYN Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ORIC) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredTrump announcement boosts “next Bitcoin”President Trump just made his first big crypto move ... Announcing the creation of a national strategic re...Weiss Ratings | SponsoredThe Worst Year in American Financial History?Economist Explains: The Curse on the U.S. Dollar Yes, there is a Curse on the U.S. Dollar... and it's behin...Stansberry Research | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ORIC Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ORIC Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ORIC Stock Free ORIC Stock Alerts